BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 24, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2021

View Archived Issues

Shire Human Genetic Therapies describes IDS gene therapy

Read More

New influenza A virus vaccine synthesized at the University of Gdansk

Read More

Pentadefenin hydrogel developed for treating vaginitis

Read More

GS-441524 is an effective antiviral against African swine fever virus in vitro

Read More

Results of phase I trial of CRAd-S-pk7 oncolytic adenovirus delivered by neural stem cells in glioma

Read More

Possible target LGALS3BP binds to SARS-CoV-2 spike glycoprotein

Read More

Sinovent patents CDK7/cyclin H inhibitors

Read More

New protein O-GlcNAcase inhibitors discovered at Janssen Pharmaceutica

Read More

Phase Ib extension data for belapectin plus Keytruda in melanoma and head and neck cancer

Read More

FDA places clinical hold on phase I/II study of SIG-001 in hemophilia A

Read More

Eli Lilly initiates phase I study of LY-3819469

Read More

Enrollment ongoing first-in-human study of PBI-200

Read More

ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults

Read More

Ranitidine bismuth citrate shows potency for treating SARS-CoV-2 infection

Read More

Rare coding variant increases risk of Y chromosome loss, diabetes

Read More

Dosing begins in phase I study in China of IBI-323 for advanced malignant tumors

Read More

FDA clears initiation of phase II trial of pyrilutamide in androgenetic alopecia

Read More

Safety monitoring committee recommends continuation of phase IIb study of RV-001 in prostate cancer

Read More

NTLA-2001 decreases serum TTR protein concentrations through targeted knockout of TTR

Read More

Ampligen to be studied in phase IIa human challenge trial as intranasal antiviral therapy

Read More

Octenidine shows potential for treating multidrug-resistant Candida infection

Read More

Preliminary phase II data with COVID-19 vaccine candidate GRAd-COV2 support progression

Read More

Inotrem gains clearance in France and Belgium to advance nangibotide for COVID-19

Read More

Enterome begins dosing in phase I/II study of EO-2463 in indolent NHL

Read More

Amniotics to advance PulmoStem into clinic next year

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing